COVID-19 Impact on Global Rapid Acting Insulins Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: CFCFDDFAF644EN
QYResearch

Abstracts

This report focuses on the global Rapid Acting Insulins status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rapid Acting Insulins development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Eli Lilly
• Novo Nordisk
• Sanofi

Market segment by Type, the product can be split into

• Lispro
• Aspart (NovoLog)
• Glulisine (Apidra)

Market segment by Application, split into

• Type 1 Diabetes
• Type 2 Diabetes

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Rapid Acting Insulins status, future forecast, growth opportunity, key market and key players.
• To present the Rapid Acting Insulins development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Rapid Acting Insulins are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rapid Acting Insulins Revenue
1.4 Market Analysis by Type
  1.4.1 Global Rapid Acting Insulins Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Lispro
  1.4.3 Aspart (NovoLog)
  1.4.4 Glulisine (Apidra)
1.5 Market by Application
  1.5.1 Global Rapid Acting Insulins Market Share by Application: 2020 VS 2026
  1.5.2 Type 1 Diabetes
  1.5.3 Type 2 Diabetes
1.6 Coronavirus Disease 2019 (Covid-19): Rapid Acting Insulins Industry Impact
  1.6.1 How the Covid-19 is Affecting the Rapid Acting Insulins Industry
    1.6.1.1 Rapid Acting Insulins Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Rapid Acting Insulins Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Rapid Acting Insulins Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Rapid Acting Insulins Market Perspective (2015-2026)
2.2 Rapid Acting Insulins Growth Trends by Regions
  2.2.1 Rapid Acting Insulins Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Rapid Acting Insulins Historic Market Share by Regions (2015-2020)
  2.2.3 Rapid Acting Insulins Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Rapid Acting Insulins Market Growth Strategy
  2.3.6 Primary Interviews with Key Rapid Acting Insulins Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Rapid Acting Insulins Players by Market Size
  3.1.1 Global Top Rapid Acting Insulins Players by Revenue (2015-2020)
  3.1.2 Global Rapid Acting Insulins Revenue Market Share by Players (2015-2020)
  3.1.3 Global Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rapid Acting Insulins Market Concentration Ratio
  3.2.1 Global Rapid Acting Insulins Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Rapid Acting Insulins Revenue in 2019
3.3 Rapid Acting Insulins Key Players Head office and Area Served
3.4 Key Players Rapid Acting Insulins Product Solution and Service
3.5 Date of Enter into Rapid Acting Insulins Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Rapid Acting Insulins Historic Market Size by Type (2015-2020)
4.2 Global Rapid Acting Insulins Forecasted Market Size by Type (2021-2026)

5 RAPID ACTING INSULINS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Rapid Acting Insulins Market Size by Application (2015-2020)
5.2 Global Rapid Acting Insulins Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Rapid Acting Insulins Market Size (2015-2020)
6.2 Rapid Acting Insulins Key Players in North America (2019-2020)
6.3 North America Rapid Acting Insulins Market Size by Type (2015-2020)
6.4 North America Rapid Acting Insulins Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Rapid Acting Insulins Market Size (2015-2020)
7.2 Rapid Acting Insulins Key Players in Europe (2019-2020)
7.3 Europe Rapid Acting Insulins Market Size by Type (2015-2020)
7.4 Europe Rapid Acting Insulins Market Size by Application (2015-2020)

8 CHINA

8.1 China Rapid Acting Insulins Market Size (2015-2020)
8.2 Rapid Acting Insulins Key Players in China (2019-2020)
8.3 China Rapid Acting Insulins Market Size by Type (2015-2020)
8.4 China Rapid Acting Insulins Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Rapid Acting Insulins Market Size (2015-2020)
9.2 Rapid Acting Insulins Key Players in Japan (2019-2020)
9.3 Japan Rapid Acting Insulins Market Size by Type (2015-2020)
9.4 Japan Rapid Acting Insulins Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Rapid Acting Insulins Market Size (2015-2020)
10.2 Rapid Acting Insulins Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rapid Acting Insulins Market Size by Type (2015-2020)
10.4 Southeast Asia Rapid Acting Insulins Market Size by Application (2015-2020)

11 INDIA

11.1 India Rapid Acting Insulins Market Size (2015-2020)
11.2 Rapid Acting Insulins Key Players in India (2019-2020)
11.3 India Rapid Acting Insulins Market Size by Type (2015-2020)
11.4 India Rapid Acting Insulins Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Rapid Acting Insulins Market Size (2015-2020)
12.2 Rapid Acting Insulins Key Players in Central & South America (2019-2020)
12.3 Central & South America Rapid Acting Insulins Market Size by Type (2015-2020)
12.4 Central & South America Rapid Acting Insulins Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Details
  13.1.2 Eli Lilly Business Overview and Its Total Revenue
  13.1.3 Eli Lilly Rapid Acting Insulins Introduction
  13.1.4 Eli Lilly Revenue in Rapid Acting Insulins Business (2015-2020))
  13.1.5 Eli Lilly Recent Development
13.2 Novo Nordisk
  13.2.1 Novo Nordisk Company Details
  13.2.2 Novo Nordisk Business Overview and Its Total Revenue
  13.2.3 Novo Nordisk Rapid Acting Insulins Introduction
  13.2.4 Novo Nordisk Revenue in Rapid Acting Insulins Business (2015-2020)
  13.2.5 Novo Nordisk Recent Development
13.3 Sanofi
  13.3.1 Sanofi Company Details
  13.3.2 Sanofi Business Overview and Its Total Revenue
  13.3.3 Sanofi Rapid Acting Insulins Introduction
  13.3.4 Sanofi Revenue in Rapid Acting Insulins Business (2015-2020)
  13.3.5 Sanofi Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Rapid Acting Insulins Key Market Segments
Table 2. Key Players Covered: Ranking by Rapid Acting Insulins Revenue
Table 3. Ranking of Global Top Rapid Acting Insulins Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rapid Acting Insulins Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lispro
Table 6. Key Players of Aspart (NovoLog)
Table 7. Key Players of Glulisine (Apidra)
Table 8. COVID-19 Impact Global Market: (Four Rapid Acting Insulins Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Rapid Acting Insulins Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Rapid Acting Insulins Players to Combat Covid-19 Impact
Table 13. Global Rapid Acting Insulins Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Rapid Acting Insulins Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Rapid Acting Insulins Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Rapid Acting Insulins Market Share by Regions (2015-2020)
Table 17. Global Rapid Acting Insulins Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Rapid Acting Insulins Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Rapid Acting Insulins Market Growth Strategy
Table 23. Main Points Interviewed from Key Rapid Acting Insulins Players
Table 24. Global Rapid Acting Insulins Revenue by Players (2015-2020) (Million US$)
Table 25. Global Rapid Acting Insulins Market Share by Players (2015-2020)
Table 26. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Acting Insulins as of 2019)
Table 27. Global Rapid Acting Insulins by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Rapid Acting Insulins Product Solution and Service
Table 30. Date of Enter into Rapid Acting Insulins Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 33. Global Rapid Acting Insulins Market Size Share by Type (2015-2020)
Table 34. Global Rapid Acting Insulins Revenue Market Share by Type (2021-2026)
Table 35. Global Rapid Acting Insulins Market Size Share by Application (2015-2020)
Table 36. Global Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 37. Global Rapid Acting Insulins Market Size Share by Application (2021-2026)
Table 38. North America Key Players Rapid Acting Insulins Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Rapid Acting Insulins Market Share (2019-2020)
Table 40. North America Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 41. North America Rapid Acting Insulins Market Share by Type (2015-2020)
Table 42. North America Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 43. North America Rapid Acting Insulins Market Share by Application (2015-2020)
Table 44. Europe Key Players Rapid Acting Insulins Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Rapid Acting Insulins Market Share (2019-2020)
Table 46. Europe Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Rapid Acting Insulins Market Share by Type (2015-2020)
Table 48. Europe Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Rapid Acting Insulins Market Share by Application (2015-2020)
Table 50. China Key Players Rapid Acting Insulins Revenue (2019-2020) (Million US$)
Table 51. China Key Players Rapid Acting Insulins Market Share (2019-2020)
Table 52. China Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 53. China Rapid Acting Insulins Market Share by Type (2015-2020)
Table 54. China Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 55. China Rapid Acting Insulins Market Share by Application (2015-2020)
Table 56. Japan Key Players Rapid Acting Insulins Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Rapid Acting Insulins Market Share (2019-2020)
Table 58. Japan Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Rapid Acting Insulins Market Share by Type (2015-2020)
Table 60. Japan Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Rapid Acting Insulins Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Rapid Acting Insulins Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Rapid Acting Insulins Market Share (2019-2020)
Table 64. Southeast Asia Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Rapid Acting Insulins Market Share by Type (2015-2020)
Table 66. Southeast Asia Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Rapid Acting Insulins Market Share by Application (2015-2020)
Table 68. India Key Players Rapid Acting Insulins Revenue (2019-2020) (Million US$)
Table 69. India Key Players Rapid Acting Insulins Market Share (2019-2020)
Table 70. India Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 71. India Rapid Acting Insulins Market Share by Type (2015-2020)
Table 72. India Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 73. India Rapid Acting Insulins Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Rapid Acting Insulins Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Rapid Acting Insulins Market Share (2019-2020)
Table 76. Central & South America Rapid Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Rapid Acting Insulins Market Share by Type (2015-2020)
Table 78. Central & South America Rapid Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Rapid Acting Insulins Market Share by Application (2015-2020)
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Product
Table 83. Eli Lilly Revenue in Rapid Acting Insulins Business (2015-2020) (Million US$)
Table 84. Eli Lilly Recent Development
Table 85. Novo Nordisk Company Details
Table 86. Novo Nordisk Business Overview
Table 87. Novo Nordisk Product
Table 88. Novo Nordisk Revenue in Rapid Acting Insulins Business (2015-2020) (Million US$)
Table 89. Novo Nordisk Recent Development
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi Product
Table 93. Sanofi Revenue in Rapid Acting Insulins Business (2015-2020) (Million US$)
Table 94. Sanofi Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Rapid Acting Insulins Market Share by Type: 2020 VS 2026
Figure 2. Lispro Features
Figure 3. Aspart (NovoLog) Features
Figure 4. Glulisine (Apidra) Features
Figure 5. Global Rapid Acting Insulins Market Share by Application: 2020 VS 2026
Figure 6. Type 1 Diabetes Case Studies
Figure 7. Type 2 Diabetes Case Studies
Figure 8. Rapid Acting Insulins Report Years Considered
Figure 9. Global Rapid Acting Insulins Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Rapid Acting Insulins Market Share by Regions: 2020 VS 2026
Figure 11. Global Rapid Acting Insulins Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Rapid Acting Insulins Market Share by Players in 2019
Figure 14. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Acting Insulins as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Rapid Acting Insulins Revenue in 2019
Figure 16. North America Rapid Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Rapid Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Rapid Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Rapid Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Rapid Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Rapid Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Rapid Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Eli Lilly Revenue Growth Rate in Rapid Acting Insulins Business (2015-2020)
Figure 25. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novo Nordisk Revenue Growth Rate in Rapid Acting Insulins Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Rapid Acting Insulins Business (2015-2020)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed